RAMP Study: A Study Comparing Two Lumbar Fusion Procedures



Status:Recruiting
Conditions:Orthopedic
Therapuetic Areas:Orthopedics / Podiatry
Healthy:No
Age Range:18 - Any
Updated:5/5/2014
Start Date:June 2012
Contact:Rebecca Gibson
Email:rebecca.gibson@baxsurg.com
Phone:1.877.493.1570

Use our guide to learn which trials are right for you!

RAMP Study: A Prospective Randomized Study Comparing Two Lumbar Fusion Procedures

This is a post-marketing, on-label Efficacy, Effectiveness and Safety Study designed in a
Multicenter, Randomized, Prospective format. This study compares two spinal fusion
procedures, Transacral Interbody Fusion and Transforaminal Lumbar Interbody Fusion (TLIF).
Enrollment period will be approximately 12-18 months; each Principal Investigator/Study
Center will be expected to enroll up to 20 subjects. The protocol requires approximately 7
subject visits to the study center from screening through the final follow-up visit.

Study Treatment Arms:

The transacral lumbar interbody fusion (including 1L+ and 2L+) is a minimally invasive
technique that uses a transacral approach to achieve fusion at the L5-S1 or L4-L5-S1 spinal
levels. The transforaminal lumbar interbody fusion (TLIF) is performed by using a posterior
unilateral or bilateral incision in which the lumbar spine is accessed. Both study
procedures are approved for use and conform to US regulatory requirements. The study
employs these procedures and devices for uses that are consistent with their 510(k), legally
cleared, labeling.

Study Design, Objective:

The study objective is to demonstrate non-inferiority between the transacral lumbar
interbody fusion procedure and the transforaminal lumbar interbody fusion procedure (TLIF)
by meeting the primary and secondary study endpoints as listed below.

Study design, Endpoints:

Primary Endpoint:

Efficacy: Fusion of the targeted vertebral bodies (L4-L5 or L5-S1) by 24 months as
determined by Central Radiographic Reviewer's interpretation of high resolution Computed
Tomography (CT) scan.

Secondary Endpoints:

Safety: Incidence of major device-related adverse events and/or failures by 24 months,
defined as those requiring revision surgery or a secondary operation, or events resulting in
permanent disability or death.

Clinical Effectiveness: A 20% decrease in back pain compared to baseline by 24 months as
measured by the Visual Analog Scale (VAS) score.

Clinical Effectiveness: A 20% decrease in disability compared to baseline by 24 months as
measured by the Oswestry Disability Index (ODI).

Study Design, Enrollment and Analyses:

Approximately 200 subjects will be enrolled in this study and will receive one of two study
treatments in the study. The enrollment period is expected to last approximately 18 months,
with a 24 month follow up period. Approximately 15-20 sites will participate, and
Investigators must be proficient in both of the lumbar fusion procedures.

Analyses:

Eight evaluations: Pre-Operative, Operative, Discharge, and at 1, 3, 6, 12, and 24 Months.

Safety and efficacy analyses will be performed at all follow-up points during the study as
well as a final analysis when all subjects have completed the study.

Inclusion Criteria:

- Male or female subject that is eligible for both study procedures only at the
L4-L5-S1 or L5-S1 levels with bilateral pedicle screws;

- The subject has a diagnosis of one or more of the following conditions at the
L4-L5-S1 or L5-S1 levels:

- Spinal stenosis;

- Spondylolisthesis;

- Degenerative Disc Disease (DDD) defined as back pain and/or radicular pain with
degeneration of the disc as confirmed by history, physical examination and
radiographic studies, either by CT, MRI, plain film, myelography, or
discography;

- Adult 18 years of age or older;

- The subject has undergone at least 6 consecutive months of Conservative Care
Therapy(ies);

- The subject is able and willing to give written informed consent and to comply with
the requirements of this study protocol.

Exclusion Criteria:

- Coagulopathy;

- Bowel disease (e.g. Crohn's, ulcerative colitis);

- Severe scoliosis (curves > 60°);

- Sacral agenesis;

- Spondylolisthesis greater than Grade 1 at the L4-L5-S1 levels, or greater than Grade
2 at the L5-S1 level;

- Spinal tumor (or history of sacral tumor);

- History of fracture at L4, L5 and/or S1 vertebral bodies;

- The subject has undergone a prior fusion procedure of the lumbar spine;

- Osteoporosis; or, if the subject is at high risk for development of osteoporosis,
further screening to be conducted at Investigator's discretion;

- Per the Investigator, body weight is exclusionary only if concomitant medical issues
are present that preclude the subject from being a candidate for spinal surgery; The
subject is a current cigarette smoker;

- For women of childbearing potential, pregnancy at the time of enrollment, or planning
to become pregnant during the course of the study;

- The subject has a history of substance abuse (illegal drugs, prescription drugs, or
alcohol) that, in the Investigator's opinion, may interfere with protocol assessments
and/or the subject's ability to comply with the protocol;

- Per the Investigator, the subject is in poor general health or undergoing any
concurrent disease process that would place the subject in excessive risk to surgery
(e.g. significant circulatory problems, cardiac disease, history of bowel surgery);

- The subject is participating in another spine study, which, in the opinion of the
Investigator, could skew results;

- The subject is involved in litigation related to their back condition;

- The subject is contraindicated to receive either study procedure;

- The subject is contraindicated to receive bilateral pedicle screws;

- The subject has a history of allergy to any component of the devices or biologic
material to be implanted in either procedure;

- The subject is a prisoner, transient, or an illegal alien.
We found this trial at
11
sites
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
8700 Beverly Blvd # 8211
Los Angeles, California 90048
(1-800-233-2771)
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Baton Rouge, Louisiana 70808
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Carmel, Indiana 46032
?
mi
from
Carmel, IN
Click here to add this to my saved trials
Cary, North Carolina 27518
?
mi
from
Cary, NC
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
11100 Euclid Ave
Cleveland, Ohio 44106
(216) 844-1000
University Hospitals of Cleveland The history of University Hospitals Case Medical Center is linked to...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
College Station, Texas 77845
?
mi
from
College Station, TX
Click here to add this to my saved trials
Danville, Virginia 24541
?
mi
from
Danville, VA
Click here to add this to my saved trials
Fullerton, California 92835
?
mi
from
Fullerton, CA
Click here to add this to my saved trials
Worcester, Massachusetts 01655
?
mi
from
Worcester, MA
Click here to add this to my saved trials